Cidara Therapeutics announces new appointment to its Scientific Advisory Board

Cidara Therapeutics announced the appointment of Rick Bright, Ph.D., Philip Krause, M.D., Mario Barro, Ph.D., and Frederick G. Hayden, M.D., FACP to its Scientific Advisory Board. Bright was most recently CEO of the Pandemic Prevention Institute at The Rockefeller Foundation. Krause has 30 years of experience at the FDA. Barro is a Venture Partner and Head of the Infectious Disease Team at RA Capital Management. Hayden is a Stuart S. Richardson Professor Emeritus of Clinical Virology and Professor Emeritus of Medicine at the University of Virginia School of Medicine in Charlottesville, Virginia, USA.